Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy. [electronic resource]
Producer: 20100713Description: 1213-20 p. digitalISSN:- 1791-2431
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asian People
- Biomarkers, Tumor -- analysis
- Biopsy
- Breast Neoplasms -- chemistry
- Chemotherapy, Adjuvant
- China
- Disease-Free Survival
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Logistic Models
- Mastectomy
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Odds Ratio
- Predictive Value of Tests
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Receptors, Progesterone -- analysis
- Recurrence
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.